BDNF and polycystic ovary syndrome: These findings suggest that within a PCOS population, VAI-defined cardiometabolic risk is associated with distinct neurotrophin-adipokine signatures, highlighting neurotrophin-adipokine networks underlying visceral adiposity-driven cardiometabolic and endocrine risk.